Biovian is a leading biopharmaceuticals development and manufacturing organization for biological processes

Biovian is a leading biopharmaceuticals development and manufacturing organization providing “one-stop-shop” services, from early development to finished vial, for biological processes such as complex microbial fermentation and gene therapy. Biovian counts c.30 active customers across the globe and is headquartered in Turku, Finland. Keensight Capital provided an equity investment alongside the management team to support the next phase of the company’s development.

Headquarter

FINLAND

Investment Year

2018

Status

CURRENT